Overdose risk prompts morphine syringe recall

Posted on

The United States Food and Drug Administration in, cooperation with the Stericycle pharmaceutics manufacturing company, has issued a safety recall for a single lot of Carpuject morphine syringes after reports that two of the syringes from this lot contained more morphine than their labeled fill volume  of 1 milliliter. A morphine overdose can cause potentially fatal medical complications such as lowered blood pressure and slowed or suspended breathing (also known as respiratory depression). The potentially mislabeled morphine syringes originated from lot number 10830LL with an April 1, 2013 expiration date, and they were distributed in January 2012 to medical centers and wholesalers throughout Texas, Colorado, Illinois, Hawaii, Michigan, Indiana, Minnesota, Ohio, Arizona and Virginia. These prefilled glass syringes were manufactured to be used with the Carpuject Syringe system. The Morphine Sulfate Carpujects 4 milligrams/milliliter are packaged in tamper detecting Slim-Pak packages containing 10 Carpujects. Medical centers or wholesalers in possession of affected syringes should separate them from the rest of their medical supply stock and return them to the manufacturer for a refund. Anyone adversely affected by this product is encouraged to contact the Food and Drug Administration’s Medwatch Adverse Event Reporting Program.

As a personal injury lawyer in Fresno, I hope this recall is carried out before anyone is harmed by this potential labeling error. If you have been injured by a mislabeled or defective product, please consider contacting a Long Beach personal injury attorney.